about
Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study.DKK-1 in prostate cancer diagnosis and follow upPathological findings of penile fractures and their surgical management.The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysisProerectile pharmacological prophylaxis following nerve-sparing radical prostatectomy (NSRP).Sexual function after surgical treatment for penile cancer: Which organ-sparing approach gives the best results?Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.Nerve-sparing radical retropubic prostatectomy: techniques and clinical considerations.Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines PaneCardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapyThe effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injuryThe role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer.Kidney radiofrequency ablation for small renal tumors: oncologic efficacy.Non-invasive methods of penile lengthening: fact or fiction?Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: results from a cross-sectional study.Genital Chlamydia trachomatis infection is related to poor sexual quality of life in young sexually active women.Retroperitoneal laparoscopic kidney biopsy: technical tips for a minimally invasive approach.Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dSense and nonsense of an extended pelvic lymph node dissection in prostate cancer.Robot-assisted laparoscopic pyeloplasty in a pediatric patient with horseshoe kidney: surgical technique and review of the literature.Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.Microwave-induced thermoablation with Amica-probe is a safe and reproducible method to treat solid renal masses: results from a phase I study.External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome.Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.Clinical judgment versus biomarker prostate cancer gene 3: which is best when determining the need for repeat prostate biopsy?Harmonized Italian version of the Aging Males' Symptoms scale.Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer.EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?Natural history of surgically treated high-risk prostate cancer.Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study.Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries?The strange case of a hematocele mistaken for a neoplastic scrotal mass.
P50
Q34701182-7EA2CC77-00D1-4560-B05F-D6756B5B7630Q35127390-6E61AFB4-5413-4766-94CE-07BDCA8A45A7Q35170278-4EDBDFF6-847E-4F8F-8344-42214A349D51Q35778867-010DE55E-8E50-4538-9FA9-9DD22677D545Q35834297-05097D03-AE06-4D06-BD31-C7C3969E55BBQ35887888-DB40D1B4-D369-4C18-8A26-5AAAC597AA75Q35909661-9D95FE9E-C1E8-487B-9B11-411DC703C62DQ35990762-4955BA57-2758-412A-BAD2-C7803C5A67EBQ36042302-ABAD4794-BC87-41D4-ACFE-D2FF0A4DBDBDQ36286371-78FB224A-DFF0-47E3-8BCB-7D81482D2D18Q36359178-6C717D4C-D7F0-4F15-B06F-511C3D01DC1BQ37234740-B4C9C410-025D-4FB8-AE2C-7EB3C8784335Q37244332-6EFD8B96-69E8-487A-AAF2-16770F8E5CCAQ37631034-581D246B-D7FC-4A56-9CD8-E52045B6F1D7Q37647214-DB51F48B-1FD6-4728-A881-B9825B776754Q37755170-3CC20C53-EF5F-462E-9968-27A5173207A9Q37792172-36114C20-77B8-4879-A4C9-47C33C09314BQ37843481-A4FB1E29-44F2-4E91-AE54-0CD69DEF64A5Q37851498-551475AD-DF2A-4B0D-8A28-F49A8488AD0EQ37937690-4F4A84E4-ACE5-44E4-84B5-02FD573B0CFDQ38147844-3AA10C00-0218-42CF-8379-780FE8CC8262Q38200568-B45426DC-9EEC-4C79-8539-8B558905FCC9Q38227082-644C6559-18B4-4B2E-BFF0-095024F158D5Q38447327-D1642DA9-7258-4600-925F-94EAE415A562Q38657139-F7F9824C-5198-4A4E-BE40-FB12B4E2A19AQ38925536-64C85805-D0E6-4A4D-99EF-1D5E8093D98EQ39078873-6F204FA8-1EF4-40B1-A69D-C4999C96E481Q39322813-BB1C1DEA-7B37-46E6-99A7-23A1CBD2E129Q39568761-736B5F42-2B38-4927-B8DD-6180F0E302F0Q39941191-AAEBCB26-A326-41DB-A3B4-359C144BA617Q39979486-B95F7053-49BC-42F2-904B-559578CF98F2Q40100316-9BA9D56C-6660-4FA3-A884-351210680288Q40360534-F03172ED-BBA3-49BC-9A04-411FD3BFD1FBQ40427246-3CC1862C-7295-40D6-801C-22B02F4D5B11Q40696118-E35FB13D-E236-420C-8DEF-9E9ADBE0E3BFQ41039911-75C2CBA3-3DC2-4B8C-8778-A1A0E4959EFEQ41459138-FF8C0CDE-E6B2-4B1D-9107-C986C9750D87Q41705995-D49183B8-6DB3-4A2C-9679-6B7B6E0BFE7FQ41868336-7CA7EAD4-4077-4B6D-8350-54B635A6A367Q42108408-AE07A661-0A55-460F-90CE-DA0A8D5E96A0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paolo Gontero
@ast
Paolo Gontero
@en
Paolo Gontero
@es
Paolo Gontero
@nl
Paolo Gontero
@sl
type
label
Paolo Gontero
@ast
Paolo Gontero
@en
Paolo Gontero
@es
Paolo Gontero
@nl
Paolo Gontero
@sl
prefLabel
Paolo Gontero
@ast
Paolo Gontero
@en
Paolo Gontero
@es
Paolo Gontero
@nl
Paolo Gontero
@sl
P106
P1153
7003279939
P21
P31
P496
0000-0002-9714-6596